X-HA3®
1st polyvalent cross-linked hyaluronic acid dermal filler
FOR IMMEDIATE, HARMONIOUS AND LONG-LASTING WRINKLE CORRECTION
INDICATION
1st polyvalent cross-linked hyaluronic acid dermal filler
1-Filling in medium and deep wrinkles
2-Re-structuring cheekbones to redefine facial contours
3-Rejuvenating lips with peribuccal wrinkle correction, contour reshaping and volume increase.
X-HA3® can treate:
Nasolabial folds
Marionette lines
Facial contours
Peribuccal wrinkles
Cheekbones
Tear trough
Glabella
Labial commissures
Lip volume
COMPOSITION
X-HA3® is the 1st polyvalent cross-linked hyaluronic acid with optimal concentration of 23mg/ml and high molecular weight.
It allows to treat medium wrinkles, deep wrinkles, lip contour and lip volume with the same syringe. .
Obtained by bio-fermentation, with no-animal origin, X-HA3 is highly purified for a perfect biocompatibility.
Technical Description
| Composition | hyaluronic acid |
| Concentration | 23mg/ml |
| Molecular weight | 2,5MDa |
| Cross-linking | BDDE |
| Packaging | 2 prefilled sterile 1ml syringes and 4 needles 27G1/2 |
PROVEN EFFICIENCY
DYNAMIC SCULPTUREFilorga has initiated a new approach of dermal filling
Polyvalence is the result of the combination of 3 properties of the hyaluronic acid X-HA3
VOLUMIZING
Only a small quantity of X-HA3 ® is sufficient to create a volume able to lift tissues in order to correct medium and deep wrinkles. This volume property is given by the unique visco-elasticity obtained thanks to an important molecular weight combined to a high concentration of hyaluronic acid and an adapted cross-linking.
MODELLING
Once injected, X-HA3 ® gel can be sculpted, modeled and easily positioned in tissues, so that it recreates harmonious contours of the face. This high modelling capacity allows the treatment of the medium depressions with natural effects.
HOMOGENEOUS
Thanks to an exceptional homogeneity,X-HA3 ® gel has an equal consistency and a uniform density, allowing a precise and regular injection, for natural results.
PROTOCOL
Each X-HA3® injection session can be completed with an NCTF 135® injection to redensify cutaneous tissues in a biological and natural way as X-HA3® resorbs.